# NAC for Treatment-Resistant OCD and Other Related Disorders

> **NCT06956157** · PHASE4 · ACTIVE_NOT_RECRUITING · sponsor: **Guangdong Provincial People's Hospital** · enrollment: 90 (estimated)

## Conditions studied

- Obsessive Compulsive Disorder (OCD)

## Interventions

- **DRUG:** N-Acetylcysteine Tablets
- **DRUG:** Placebo Oral Tablet

## Key facts

- **NCT ID:** NCT06956157
- **Lead sponsor:** Guangdong Provincial People's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-06-22
- **Primary completion:** 2024-11-13
- **Final completion:** 2025-11-13
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2025-09-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06956157

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06956157, "NAC for Treatment-Resistant OCD and Other Related Disorders". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06956157. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*